J. Davies (London, United Kingdom), S. Graeber (Berlin, Germany)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis?
J. Grosse-Onnebrink (Münster, Germany), V. Mete (Münster, Germany), K. Kolonko (Münster, Germany), S. Cindric (Münster, Germany), S. Helms (Münster, Germany), H. Omran (Münster, Germany), W. Weber (Münster, Germany)
|  |
Cross-sectional and longitudinal comparison of N2 and SF6 multiple breath washout in infants and toddlers with CF and healthy controls
R. Sandvik (Copenhagen, Denmark), M. Schmidt (Copenhagen, Denmark), J. Olsen (Aarhus, Denmark), S. Rubak (Aarhus, Denmark), A. Lindblad (Gothenburg, Sweden), H. Olesen (Aarhus, Denmark), F. Buchvald (Copenhagen, Denmark), T. Pressler (Copenhagen, Denmark), M. Skov (Copenhagen, Denmark), P. Gustafsson (Skövde, Sweden), K. Nielsen (Copenhagen, Denmark)
|   |
Longitudinal SF6 multiple breath washout in infants and toddlers with cystic fibrosis
R. Sandvik (Copenhagen, Denmark), M. Schmidt (Copenhagen, Denmark), M. Kragh (Copenhagen, Denmark), C. Voldby (Copenhagen, Denmark), F. Buchvald (Copenhagen, Denmark), T. Pressler (Copenhagen, Denmark), A. Lindblad (Gothenburg, Sweden), M. Skov (Copenhagen, Denmark), P. Gustafsson (Skövde, Sweden), K. Nielsen (Copenhagen, Denmark)
| |
Changes in the Lung Clearance Index outside 15% are clinically relevant in children with cystic fibrosis
L. Perrem (Toronto (ON), Canada), S. Stanojevic (Nova Scotia, Canada), S. Davis (Chapel Hill, United States of America), D. Sanders (Indianapolis, United States of America), R. Jensen (Toronto, Canada), M. Shaw (Toronto, Canada), M. Solomon (Toronto, Canada), H. Grasemann (Toronto, Canada), V. Waters (Toronto, Canada), N. Sweezey (Toronto, Canada), N. Mcdonald (Toronto, Canada), J. Guido (Toronto, Canada), C. Clem (Indianapolis, United States of America), F. Ratjen (Indianapolis, United States of America)
| |
Evolution of lung clearance index during the first year of life in cystic fibrosis
M. Oestreich (Bern, Switzerland), T. Manogaran (Bern, Switzerland), B. Frauchiger (Bern, Switzerland), A. Kentgens (Bern, Switzerland), J. Kurz (Bern, Switzerland), P. Latzin (Bern, Switzerland), K. Ramsey (Bern, Switzerland)
| |
Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
B. Frauchiger (Bern, Switzerland), K. Ramsey (Bern, Switzerland), J. Usemann (Zurich, Switzerland), E. Kieninger (Bern, Switzerland), C. Casaulta (Bern, Switzerland), S. Yammine (Bern, Switzerland), D. Sirtes (Bern, Switzerland), B. Spycher (Bern, Switzerland), A. Moeller (Zurich, Switzerland), P. Latzin (Bern, Switzerland)
| |
Change in functional lung MRI and multiple breath washout outcomes over one year in children with cystic fibrosis
C. Willers (Bern, Switzerland), B. Frauchiger (Bern, Switzerland), E. Stranzinger (Bern, Switzerland), G. Bauman (Basel, Switzerland), O. Pusterla (Basel, Switzerland), O. Bieri (Basel, Switzerland), K. Ramsey (Bern, Switzerland), P. Latzin (Bern, Switzerland)
| |
Sensitive automated airway-artery method to monitor progression of CF airway disease
Q. Lv (Rotterdam, Netherlands), R. Sandvik (Copenhagen, Denmark), K. Nielsen (Copenhagen, Denmark), E. Andrinopoulou (Rotterdam, Netherlands), L. Gallardo-Estrella (Nijmegen, Netherlands), J. Charbonnier (Nijmegen, Netherlands), H. Tiddens (Rotterdam, Netherlands)
| |
Evaluation of SnIII parameters as outcome measures of multiple breath washout (MBW) in preschool children with cystic fibrosis
M. Dumas (Toronto, Canada), N. Karsli (Toronto, Canada), R. Jensen (Toronto, Canada), F. Ratjen (Toronto, Canada)
| |
Late Breaking Abstract - Depression and anxiety in patients with cystic fibrosis before and during Covid 19 pandemic
K. Skenderaj (Parma, Italy), V. Fainardi (Parma, Italy), S. Dioni (Parma, Italy), S. Esposito (Parma, Italy), G. Pisi (Parma, Italy)
| |
Discussion
| |